Medical Nutrition Market Share Analysis
Significant part of the medical nutrition market, especially during the early stages of a child's life. Inadequate nutrition during infancy can lead to various issues like growth problems, increased infection risk, and even conditions like blindness and anemia. Premature births, which are more common in countries with high birth rates, pose even greater risks for infants. Babies born prematurely are more susceptible to sensory deficits, cerebral palsy, learning disabilities, and respiratory illnesses compared to those born full-term.
Pediatric formula products, crucial for infant nutrition, are readily available in supermarkets and other retail channels. These formulas come in three main formats: powder, liquid concentrate, and ready-to-feed. Powder and liquid concentrates are more affordable but require mixing or dilution. On the other hand, ready-to-feed formulas are the most convenient, not requiring any dilution with water. However, they tend to be more expensive than powder and liquid concentrate formulas. Key players in the infant nutrition market include Mead Johnson, Abbott, Nestle, and Danone.
Parenteral nutrition involves delivering nutrients directly into the bloodstream through intravenous feeding. This method is used when patients cannot meet their daily nutritional needs through normal digestion, especially when they are unable to eat, digest, and consume nutrients. While parenteral nutrition is expensive, costing around USD 100,000 per year, it becomes essential for patients who need immediate and concentrated feeding due to conditions like severe burns, cancer, gastrointestinal diseases, and AIDS. The increasing aging population and the development of new products designed for home care settings are driving the growth of the parenteral nutrition segment. Major companies in the parenteral nutrition market include Baxter, B. Braun, Fresenius Kabi, and Hospira.
Pediatric nutrition is a crucial aspect of the medical nutrition market, particularly in the early stages of a child's life. Inadequate nutrition during infancy can lead to various problems such as growth retardation, increased susceptibility to infections, and the risk of conditions like blindness and anemia. Premature births, which are more common in countries with high birth rates, pose even greater risks for infants. Babies born prematurely are more vulnerable to issues like sensory deficits, cerebral palsy, learning disabilities, and respiratory illnesses compared to those born full-term.
Pediatric formula products, essential for infant nutrition, are readily available in supermarkets and various retail channels. These formulas come in three main formats: powder, liquid concentrate, and ready-to-feed. Powder and liquid concentrates are more budget-friendly but require mixing or dilution. On the other hand, ready-to-feed formulas are the most convenient, not requiring any dilution with water. However, they tend to be more expensive than powder and liquid concentrate formulas. Key players in the infant nutrition market include Mead Johnson, Abbott, Nestle, and Danone.
Parenteral nutrition involves delivering nutrients directly into the bloodstream through intravenous feeding. This method is used when patients cannot meet their daily nutritional needs through normal digestion, especially when they are unable to eat, digest, and consume nutrients. While parenteral nutrition is expensive, costing around USD 100,000 per year, it becomes essential for patients who need immediate and concentrated feeding due to conditions like severe burns, cancer, gastrointestinal diseases, and AIDS. The increasing aging population and the development of new products designed for home care settings are driving the growth of the parenteral nutrition segment. Major companies in the parenteral nutrition market include Baxter, B. Braun, Fresenius Kabi, and Hospira.
